SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-16-010536
Filing Date
2016-07-13
Accepted
2016-07-13 16:41:06
Documents
59
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 384750
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7168
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 7276
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2820
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2956
  Complete submission text file 0001062993-16-010536.txt   3671680

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lxrp-20160531.xml EX-101.INS 279647
7 XBRL SCHEMA FILE lxrp-20160531.xsd EX-101.SCH 123907
8 XBRL CALCULATION FILE lxrp-20160531_cal.xml EX-101.CAL 49835
9 XBRL DEFINITION FILE lxrp-20160531_def.xml EX-101.DEF 374139
10 XBRL LABEL FILE lxrp-20160531_lab.xml EX-101.LAB 790780
11 XBRL PRESENTATION FILE lxrp-20160531_pre.xml EX-101.PRE 417340
Mailing Address SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 V6E 4A4
Business Address SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 V6E 4A4 604-602-1675
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52138 | Film No.: 161765953
SIC: 1000 Metal Mining